Clinical trial
Axillary Reverse Mapping in Breast Cancer
NCT01038908 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Axillary Reverse Mapping in Breast Cancer
- Lead sponsor
- University of British Columbia
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- June 30, 2014
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer